Sun Pharmaceutical vs Torrent Pharma: share price, P/E, ROE and financials compared
Sun Pharmaceutical Industries
Torrent Pharmaceuticals
Sun Pharmaceutical and Torrent Pharma at a glance
Sun Pharmaceutical and Torrent Pharma are both listed in Healthcare. Sun Pharmaceutical is the larger by market cap, at ₹4.5L Cr against ₹1.8L Cr for Torrent Pharma (2.5 times as large). On valuation, Sun Pharmaceutical has the lower P/E (40.7× against 80.2×) and the lower price-to-book (4.99× against 9.83×). On returns and margins, Sun Pharmaceutical has the higher ROCE (17.9% against 9.1%), while Torrent Pharma has the higher ROE (15.7% against 13.1%) and the higher operating margin (33.7% against 28.2%). Over three years, Torrent Pharma has faster 3-year sales growth (+13.3% against +10.4% a year) and faster 3-year profit growth (+20.2% against +10.6% a year). Sun Pharmaceutical carries less debt for its equity, with a debt-to-equity of 0.04× against 0.77×.
Key metrics, side by side
| Metric | Sun PharmaceuticalSUNPHARMA | Torrent PharmaTORNTPHARM |
|---|---|---|
| Price (₹) | 1,860.00 | 4,750.00 |
| Market cap (₹ Cr) | 4,46,276 | 1,80,675 |
| P/E | 40.7× (the lower figure, shaded) | 80.2× |
| P/B | 4.99× (the lower figure, shaded) | 9.83× |
| Dividend yield, trailing | 0.86% | 0.80% |
| ROE | 13.1% | 15.7% (the higher figure, shaded) |
| ROCE | 17.9% (the higher figure, shaded) | 9.1% |
| Operating margin (OPM) | 28.2% | 33.7% (the higher figure, shaded) |
| Net margin (NPM) | 17.8% (the higher figure, shaded) | 12.2% |
| Sales CAGR 3Y | +10.4% | +13.3% (the higher figure, shaded) |
| Profit CAGR 3Y | +10.6% | +20.2% (the higher figure, shaded) |
| Debt to equity | 0.04× (the lower figure, shaded) | 0.77× |
| Interest cover | 45.6× (the higher figure, shaded) | 8.5× |
| Net profit TTM (₹ Cr) | 10,966 | 2,124 |
| 1Y return | +8.2% | +31.7% (the higher figure, shaded) |
| Promoter holding | – | 60.78% |
Sun Pharmaceutical vs Torrent Pharma: common questions
Which is bigger, Sun Pharmaceutical or Torrent Pharma?
By market cap, Sun Pharmaceutical is bigger at ₹4.5L Cr, against ₹1.8L Cr for Torrent Pharma (prices as of 6 Nov 2026). Net profit over the last twelve months was ₹10,966 Cr for Sun Pharmaceutical and ₹2,124 Cr for Torrent Pharma.
Which has a lower P/E ratio, Sun Pharmaceutical or Torrent Pharma?
Sun Pharmaceutical trades at a P/E of 40.7× and Torrent Pharma at 80.2×. Sun Pharmaceutical has the lower P/E. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.
Which has a higher ROE, Sun Pharmaceutical or Torrent Pharma?
Sun Pharmaceutical reports a return on equity of 13.1% and Torrent Pharma 15.7%. Torrent Pharma has the higher ROE. ROE is net profit as a share of shareholders’ equity.
Which is growing faster, Sun Pharmaceutical or Torrent Pharma?
Over the last three years: Sales grew +10.4% a year at Sun Pharmaceutical and +13.3% at Torrent Pharma, so Torrent Pharma grew sales faster; profit grew +10.6% a year at Sun Pharmaceutical and +20.2% at Torrent Pharma, so Torrent Pharma grew profit faster. Past growth doesn’t predict future growth.